Envestnet Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.11M | Buy |
|
|||||
|
2025
Q1 | $2.8M | Sell |
|
|||||
|
2024
Q4 | $9.34M | Buy |
|
|||||
|
2024
Q3 | $8.64M | Buy |
|
|||||
|
2024
Q2 | $6.71M | Buy |
|
|||||
|
2024
Q1 | $3.94M | Buy |
|
|||||
|
2023
Q4 | $3.22M | Buy |
|
|||||
|
2023
Q3 | $2.62M | Buy |
|
|||||
|
2023
Q2 | $2.73M | Sell |
|
|||||
|
2023
Q1 | $2.37M | Buy |
|
|||||
|
2022
Q4 | $2.04M | Sell |
|
|||||
|
2022
Q3 | $2.6M | Buy |
|
|||||
|
2022
Q2 | $2.38M | Buy |
|
|||||
|
2022
Q1 | $2.65M | Buy |
|
|||||
|
2021
Q4 | $3.33M | Buy |
|
|||||
|
2021
Q3 | $2.25M | Buy |
|
|||||
|
2021
Q2 | $1.98M | Buy |
|
|||||
|
2021
Q1 | $1.55M | Sell |
|
|||||
|
2020
Q4 | $1.34M | Sell |
|
|||||
|
2020
Q3 | $2.2M | Buy |
|
|||||
|
2020
Q2 | $2.27M | Buy |
|
|||||
|
2020
Q1 | $1.47M | Buy |
|
|||||
|
2019
Q4 | $1.69M | Sell |
|
|||||
|
2019
Q3 | $2M | Sell |
|
|||||
|
2019
Q2 | $2.38M | Buy |
|
|||||
|
2019
Q1 | $2.23M | Buy |
|
|||||
|
2018
Q4 | $1.91M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.2M | Sell |
|
|||||
|
2018
Q1 | $968K | Sell |
|
|||||
|
2017
Q4 | $922K | Buy |
|
|||||
|
2017
Q3 | $905K | Buy |
|
|||||
|
2017
Q2 | $709K | Buy |
|
|||||
|
2017
Q1 | $610K | Buy |
|
|||||
|
2016
Q4 | $551K | Buy |
|
|||||
|
2016
Q3 | $492K | Sell |
|
|||||
|
2016
Q2 | $606K | Buy |
|
|||||
|
2016
Q1 | $516K | Buy |
|
|||||
|
2015
Q4 | $433K | Buy |
|
|||||
|
2015
Q3 | $287K | Buy |
|
|||||
|
2015
Q2 | $206K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $23K | Buy |
|
|||||
|
2014
Q3 | $19K | Buy |
|
|||||
|
2014
Q2 | $12K | Buy |
|
|||||
|
2014
Q1 | $7K | Buy |
|